Similarly, doxorubicin encapsulating liposomes, decorated with the CXCR4 antagonist cyclic peptide R, significantly reduced the effective doxorubicin dose and lung metastases in a mouse model of melanoma [209]. The gene discussed is CXCR4; the disease is melanoma.